These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 13935514)

  • 1. [Morphology of the blood lipid curve after loading in Cushing's syndrome and hyperpancorticism caused by prolonged cortisone-like therapy].
    MICHELE M
    Sicil Sanit; 1961 Dec; 14():529-30. PubMed ID: 13935514
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary free cortisol and cortisone determined by high performance liquid chromatography in the diagnosis of Cushing's syndrome.
    Lin CL; Wu TJ; Machacek DA; Jiang NS; Kao PC
    J Clin Endocrinol Metab; 1997 Jan; 82(1):151-5. PubMed ID: 8989250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [SOME ASPECTS OF LIPIDOGENESIS AND STEROIDOGENESIS IN CUSHING'S SYNDROME. STUDY MADE WITH ACETATE-C14].
    PICCARDO MG; JACOBELLI A; CAPURSO L; DONATI L; LUZIETTI L
    Folia Endocrinol; 1963 Dec; 16():633-44. PubMed ID: 14152429
    [No Abstract]   [Full Text] [Related]  

  • 4. CUSHING'S DISEASE AND POST-ADRENALECTOMY HYPERPIGMENTATION.
    MULLICAN WS
    J Indiana State Med Assoc; 1964 Apr; 57():331-5. PubMed ID: 14136833
    [No Abstract]   [Full Text] [Related]  

  • 5. METABOLISM OF CORTISOL BY THE HUMAN ADRENAL CORTEX IN VITRO.
    JENKINS JS
    J Clin Endocrinol Metab; 1965 May; 25():649-54. PubMed ID: 14313759
    [No Abstract]   [Full Text] [Related]  

  • 6. A FOUR-DAY CORTICOTROPHIN-SUPPRESSION TEST. STUDIES IN CUSHING'S SYNDROME AND IN NON CUSHING SUBJECTS WITH RELATED SYMPTOMS.
    ERNEST I
    Acta Endocrinol (Copenh); 1965 Jan; 48():147-62. PubMed ID: 14254767
    [No Abstract]   [Full Text] [Related]  

  • 7. [INTRACUTANEOUS HEMORRHAGES CAUSED BY SCRATCHING].
    ANTHONISEN P; CHRISTOFFERSEN P; SCHOURUP K; SCHWARTZ M
    Ugeskr Laeger; 1964 Mar; 126():379-84. PubMed ID: 14142328
    [No Abstract]   [Full Text] [Related]  

  • 8. [THE RISK OF PROLONGED THERAPY WITH CORTISONE DERIVATIVES IN RHEUMATOLOGY].
    ISEMEIN L; REDON M; TABAU R
    Poumon Coeur; 1963; 19():1195-203. PubMed ID: 14105656
    [No Abstract]   [Full Text] [Related]  

  • 9. EFFECT OF CORTICOSTEROIDS ON SERUM GROWTH HORMONE.
    HARTOG M; GAAFAR MA; FRASER R
    Lancet; 1964 Aug; 2(7356):376-8. PubMed ID: 14173624
    [No Abstract]   [Full Text] [Related]  

  • 10. [GOUT AND CORTICOTHERAPY].
    MUGLER A
    Rein Foie; 1963; 6():173-80. PubMed ID: 14111175
    [No Abstract]   [Full Text] [Related]  

  • 11. Absence of Cushingoid phenotype in a patient with Cushing's disease due to defective cortisone to cortisol conversion.
    Tomlinson JW; Draper N; Mackie J; Johnson AP; Holder G; Wood P; Stewart PM
    J Clin Endocrinol Metab; 2002 Jan; 87(1):57-62. PubMed ID: 11788623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of canine Cushing's syndrome based on multiple steroid analysis and dexamethasone turnover kinetics.
    Lothrop CD; Oliver JW
    Am J Vet Res; 1984 Nov; 45(11):2304-9. PubMed ID: 6098199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CUSHING'S SYNDROME IN A RHEUMATOID ARTHRITIS PATIENT FOLLOWING PROLONGED CORTICOTHERAPY].
    OBRADOV S; DJUGUMOVIC Z; TOMIC S; SELAK I; CUSTOVIC K
    Med Glas; 1964 Nov; 18():364-6. PubMed ID: 14312675
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma 17-hydroxycorticosteroids in Cushing's syndrome.
    EKMAN H; HAKANSSON B; McARTHY JD; LEHMANN J; SJOGREN B
    J Clin Endocrinol Metab; 1961 Jun; 21():684-94. PubMed ID: 13726263
    [No Abstract]   [Full Text] [Related]  

  • 15. FREE AND CONJUGATED PLASMA 17-HYDROXYCORTICOSTEROIDS (17-OHCS) IN THE ADRENAL VENOUS BLOOD IN CUSHING'S SYNDROME.
    WAJCHENBERG BL; GOIS GM
    Arq Bras Endocrinol Metabol; 1963 Dec; 12():221-3. PubMed ID: 14164201
    [No Abstract]   [Full Text] [Related]  

  • 16. [ADRENAL CORTEX FUNCTION. DETERMINATION OF THE URINARY AND PLASMATIC 17,21-DIHYDROXY-20-KETOSTEROIDS IN THE DIAGNOSIS OF CUSHING'S SYNDROME].
    WAJCHENBERG BL
    Arq Bras Endocrinol Metabol; 1963 Dec; 12():153-76. PubMed ID: 14164197
    [No Abstract]   [Full Text] [Related]  

  • 17. [PRINCIPAL INDICATIONS OF CORTISONE-LIKE DRUGS AND COMPLICATIONS FOLLOWING THEIR USE].
    HERNANDO T
    Prog Ter Clin; 1963 Jul; 16():785-808. PubMed ID: 14069181
    [No Abstract]   [Full Text] [Related]  

  • 18. Cushing's syndrome: hidden risk in usage of topical corticosteroids.
    Buluş AD; Andıran N; Koçak M
    J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):977-81. PubMed ID: 24854522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Marked Cushing-like appearance, complication of prolonged corticoid therapy of chronic rheumatoid polyarthritis].
    RAVAULT P; PUTELAT R; BERTRAND J; TRILLET M
    Lyon Med; 1960 Feb; 92():539-48. PubMed ID: 14436521
    [No Abstract]   [Full Text] [Related]  

  • 20. CONCENTRATION OF CORTICOSTERONE AND HYDROCORTISONE IN THE PLASMA OF PATIENTS WITH CUSHING'S SYNDROME CAUSED BY HYPERPLASIA OR TUMOUR OF THE ADRENAL CORTEX.
    BRORSON I
    Acta Chir Scand; 1964; 127():162-71. PubMed ID: 14104698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.